Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial-Reference-Cited by-同舟云学术

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

Published:2005-06 Issue:6 Volume:6 Page:369-376
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Reni Michele,Cordio Stefano,Milandri Carlo,Passoni Paolo,Bonetto Elisa,Oliani Cristina,Luppi Gabriele,Nicoletti Roberto,Galli Laura,Bordonaro Roberto,Passardi Alessandro,Zerbi Alessandro,Balzano Gianpaolo,Aldrighetti Luca,Staudacher Carlo,Villa Eugenio,Di Carlo Valerio

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

2. Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297;Berlin;J Clin Oncol,2002

3. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2003

4. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate;Rocha Lima;J Clin Oncol,2004

5. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer;Bramhall;Br J Cancer,2002

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life;Digestive and Liver Disease;2024-07

2. Efficacy and safety of first-line chemotherapies for patients with advanced pancreatic ductal adenocarcinoma: A systematic review and network meta-analysis;Heliyon;2024-04

3. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations;International Journal of Nanomedicine;2024-04

4. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. Advances in the management of pancreatic cancer;BMJ;2023-12-13